Clinical Trial Update: Subanesthetic Esketamine in Modified ECT for Severe Depression in Adolescents: Clinical and Mechanistic Study [EARLY_Phase 1]

View source ↗

Summary

An early-phase study is evaluating subanesthetic esketamine as an adjunct to modified electroconvulsive therapy for severe depression in adolescents. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• SPRAVATO (ESKETAMINE HYDROCHLORIDE)

Snippet

Sponsor: Min Su | Conditions: Esketamine, ECT | EARLY_Phase 1 | Status: RECRUITING